nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—SERPINA6—Triamcinolone—multiple sclerosis	0.29	0.417	CbGbCtD
Mitotane—SERPINA6—Prednisolone—multiple sclerosis	0.245	0.353	CbGbCtD
Mitotane—CYP11A1—Dexamethasone—multiple sclerosis	0.16	0.23	CbGbCtD
Mitotane—FDX1—Metabolism of steroid hormones and vitamin D—CYP24A1—multiple sclerosis	0.00923	0.0816	CbGpPWpGaD
Mitotane—FDX1—Metabolism of steroid hormones and vitamin D—CYP27B1—multiple sclerosis	0.00923	0.0816	CbGpPWpGaD
Mitotane—FDX1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00572	0.0506	CbGpPWpGaD
Mitotane—FDX1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00572	0.0506	CbGpPWpGaD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00464	0.041	CbGpPWpGaD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00464	0.041	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of steroid hormones and vitamin D—CYP27B1—multiple sclerosis	0.00329	0.0291	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of steroid hormones and vitamin D—CYP24A1—multiple sclerosis	0.00329	0.0291	CbGpPWpGaD
Mitotane—FDX1—medulla oblongata—multiple sclerosis	0.00297	0.106	CbGeAlD
Mitotane—CYP11A1—Metabolism of steroid hormones and vitamin D—CYP27B1—multiple sclerosis	0.00281	0.0249	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of steroid hormones and vitamin D—CYP24A1—multiple sclerosis	0.00281	0.0249	CbGpPWpGaD
Mitotane—FDX1—Endogenous sterols—POMC—multiple sclerosis	0.00277	0.0245	CbGpPWpGaD
Mitotane—FDX1—midbrain—multiple sclerosis	0.00272	0.0973	CbGeAlD
Mitotane—FDX1—spinal cord—multiple sclerosis	0.00265	0.0949	CbGeAlD
Mitotane—FDX1—Biological oxidations—CYP24A1—multiple sclerosis	0.00246	0.0218	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—CYP27B1—multiple sclerosis	0.00246	0.0218	CbGpPWpGaD
Mitotane—CYP11B1—Glucocorticoid biosynthesis—POMC—multiple sclerosis	0.0023	0.0203	CbGpPWpGaD
Mitotane—FDX1—nervous system—multiple sclerosis	0.00223	0.08	CbGeAlD
Mitotane—FDX1—central nervous system—multiple sclerosis	0.00215	0.077	CbGeAlD
Mitotane—FDX1—cerebellum—multiple sclerosis	0.0021	0.0753	CbGeAlD
Mitotane—FDX1—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	0.00208	0.0183	CbGpPWpGaD
Mitotane—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00204	0.018	CbGpPWpGaD
Mitotane—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00204	0.018	CbGpPWpGaD
Mitotane—CYP11B1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00201	0.0178	CbGpPWpGaD
Mitotane—CYP11B1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00201	0.0178	CbGpPWpGaD
Mitotane—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00174	0.0154	CbGpPWpGaD
Mitotane—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00174	0.0154	CbGpPWpGaD
Mitotane—CYP11A1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00172	0.0152	CbGpPWpGaD
Mitotane—CYP11A1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00172	0.0152	CbGpPWpGaD
Mitotane—FDX1—brain—multiple sclerosis	0.00171	0.0612	CbGeAlD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00165	0.0146	CbGpPWpGaD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00165	0.0146	CbGpPWpGaD
Mitotane—SHBG—brainstem—multiple sclerosis	0.00155	0.0556	CbGeAlD
Mitotane—CYP11A1—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	0.00144	0.0128	CbGpPWpGaD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00141	0.0125	CbGpPWpGaD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00141	0.0125	CbGpPWpGaD
Mitotane—CYP11A1—medulla oblongata—multiple sclerosis	0.00135	0.0484	CbGeAlD
Mitotane—FDX1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00129	0.0114	CbGpPWpGaD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.00104	0.00922	CbGpPWpGaD
Mitotane—CYP11A1—nervous system—multiple sclerosis	0.00101	0.0363	CbGeAlD
Mitotane—CYP11B1—Endogenous sterols—POMC—multiple sclerosis	0.000988	0.00873	CbGpPWpGaD
Mitotane—CYP11A1—central nervous system—multiple sclerosis	0.000977	0.035	CbGeAlD
Mitotane—SERPINA6—nervous system—multiple sclerosis	0.000965	0.0346	CbGeAlD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000946	0.00836	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000946	0.00836	CbGpPWpGaD
Mitotane—SHBG—Nongenotropic Androgen signaling—MAPK1—multiple sclerosis	0.000936	0.00827	CbGpPWpGaD
Mitotane—SERPINA6—central nervous system—multiple sclerosis	0.000929	0.0333	CbGeAlD
Mitotane—SERPINA6—cerebellum—multiple sclerosis	0.000908	0.0325	CbGeAlD
Mitotane—CYP11B1—Biological oxidations—CYP27B1—multiple sclerosis	0.000878	0.00776	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—CYP24A1—multiple sclerosis	0.000878	0.00776	CbGpPWpGaD
Mitotane—CYP11B1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000866	0.00765	CbGpPWpGaD
Mitotane—CYP11B1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000866	0.00765	CbGpPWpGaD
Mitotane—CYP11A1—Endogenous sterols—POMC—multiple sclerosis	0.000845	0.00746	CbGpPWpGaD
Mitotane—SHBG—central nervous system—multiple sclerosis	0.000783	0.028	CbGeAlD
Mitotane—CYP11A1—brain—multiple sclerosis	0.000776	0.0278	CbGeAlD
Mitotane—SHBG—cerebellum—multiple sclerosis	0.000765	0.0274	CbGeAlD
Mitotane—CYP11A1—Biological oxidations—CYP27B1—multiple sclerosis	0.000751	0.00664	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—CYP24A1—multiple sclerosis	0.000751	0.00664	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000741	0.00654	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000741	0.00654	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	0.00074	0.00654	CbGpPWpGaD
Mitotane—SERPINA6—brain—multiple sclerosis	0.000738	0.0264	CbGeAlD
Mitotane—CYP11A1—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	0.000633	0.00559	CbGpPWpGaD
Mitotane—SHBG—brain—multiple sclerosis	0.000622	0.0223	CbGeAlD
Mitotane—FDX1—Metabolism—SRM—multiple sclerosis	0.000598	0.00528	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—POMC—multiple sclerosis	0.000554	0.0049	CbGpPWpGaD
Mitotane—CYP11B1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000459	0.00405	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CYP24A1—multiple sclerosis	0.000421	0.00372	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CYP27B1—multiple sclerosis	0.000421	0.00372	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000412	0.00364	CbGpPWpGaD
Mitotane—CYP11A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000392	0.00347	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GPC5—multiple sclerosis	0.000386	0.00341	CbGpPWpGaD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000372	0.00328	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—TLR4—multiple sclerosis	0.000372	0.00328	CbGpPWpGaD
Mitotane—Gynaecomastia—Methotrexate—multiple sclerosis	0.000357	0.00218	CcSEcCtD
Mitotane—Lethargy—Prednisone—multiple sclerosis	0.000354	0.00216	CcSEcCtD
Mitotane—Infection—Azathioprine—multiple sclerosis	0.000352	0.00214	CcSEcCtD
Mitotane—Muscular weakness—Dexamethasone—multiple sclerosis	0.000351	0.00214	CcSEcCtD
Mitotane—Muscular weakness—Betamethasone—multiple sclerosis	0.000351	0.00214	CcSEcCtD
Mitotane—Osteoarthritis—Prednisone—multiple sclerosis	0.000347	0.00211	CcSEcCtD
Mitotane—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000346	0.00211	CcSEcCtD
Mitotane—Body temperature increased—Cladribine—multiple sclerosis	0.000344	0.0021	CcSEcCtD
Mitotane—Skin disorder—Azathioprine—multiple sclerosis	0.000344	0.00209	CcSEcCtD
Mitotane—Dysgeusia—Mitoxantrone—multiple sclerosis	0.000343	0.00209	CcSEcCtD
Mitotane—Infestation—Methylprednisolone—multiple sclerosis	0.000338	0.00206	CcSEcCtD
Mitotane—Infestation NOS—Methylprednisolone—multiple sclerosis	0.000338	0.00206	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000337	0.00298	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000337	0.00298	CbGpPWpGaD
Mitotane—Irritability—Prednisone—multiple sclerosis	0.000331	0.00202	CcSEcCtD
Mitotane—Hypotension—Azathioprine—multiple sclerosis	0.000331	0.00201	CcSEcCtD
Mitotane—Vision blurred—Mitoxantrone—multiple sclerosis	0.00033	0.00201	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—POMC—multiple sclerosis	0.000326	0.00288	CbGpPWpGaD
Mitotane—Anaemia—Mitoxantrone—multiple sclerosis	0.000324	0.00197	CcSEcCtD
Mitotane—Hypersensitivity—Cladribine—multiple sclerosis	0.000321	0.00195	CcSEcCtD
Mitotane—FDX1—Metabolism—RRM1—multiple sclerosis	0.000319	0.00282	CbGpPWpGaD
Mitotane—Visual impairment—Prednisolone—multiple sclerosis	0.000318	0.00194	CcSEcCtD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000318	0.00281	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—TLR4—multiple sclerosis	0.000318	0.00281	CbGpPWpGaD
Mitotane—Asthenia—Cladribine—multiple sclerosis	0.000312	0.0019	CcSEcCtD
Mitotane—Muscular weakness—Prednisone—multiple sclerosis	0.000306	0.00186	CcSEcCtD
Mitotane—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000305	0.00186	CcSEcCtD
Mitotane—Hypertension—Mitoxantrone—multiple sclerosis	0.000303	0.00184	CcSEcCtD
Mitotane—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.000298	0.00181	CcSEcCtD
Mitotane—Diarrhoea—Cladribine—multiple sclerosis	0.000298	0.00181	CcSEcCtD
Mitotane—Lethargy—Methotrexate—multiple sclerosis	0.000296	0.0018	CcSEcCtD
Mitotane—Visual impairment—Methylprednisolone—multiple sclerosis	0.000292	0.00178	CcSEcCtD
Mitotane—Feeling abnormal—Azathioprine—multiple sclerosis	0.000292	0.00178	CcSEcCtD
Mitotane—Osteoarthritis—Methotrexate—multiple sclerosis	0.00029	0.00177	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000288	0.00255	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000288	0.00255	CbGpPWpGaD
Mitotane—Confusional state—Mitoxantrone—multiple sclerosis	0.000288	0.00176	CcSEcCtD
Mitotane—Dizziness—Cladribine—multiple sclerosis	0.000288	0.00175	CcSEcCtD
Mitotane—Infection—Mitoxantrone—multiple sclerosis	0.000284	0.00173	CcSEcCtD
Mitotane—Eye disorder—Methylprednisolone—multiple sclerosis	0.000283	0.00173	CcSEcCtD
Mitotane—Shock—Mitoxantrone—multiple sclerosis	0.000281	0.00171	CcSEcCtD
Mitotane—Neutropenia—Prednisone—multiple sclerosis	0.00028	0.00171	CcSEcCtD
Mitotane—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.00028	0.00171	CcSEcCtD
Mitotane—Body temperature increased—Azathioprine—multiple sclerosis	0.00028	0.0017	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—POMC—multiple sclerosis	0.000279	0.00246	CbGpPWpGaD
Mitotane—Skin disorder—Mitoxantrone—multiple sclerosis	0.000278	0.00169	CcSEcCtD
Mitotane—Irritability—Methotrexate—multiple sclerosis	0.000277	0.00169	CcSEcCtD
Mitotane—Vomiting—Cladribine—multiple sclerosis	0.000277	0.00169	CcSEcCtD
Mitotane—Angiopathy—Methylprednisolone—multiple sclerosis	0.000275	0.00167	CcSEcCtD
Mitotane—Rash—Cladribine—multiple sclerosis	0.000274	0.00167	CcSEcCtD
Mitotane—Dermatitis—Cladribine—multiple sclerosis	0.000274	0.00167	CcSEcCtD
Mitotane—Anorexia—Mitoxantrone—multiple sclerosis	0.000273	0.00166	CcSEcCtD
Mitotane—Ataxia—Methotrexate—multiple sclerosis	0.000273	0.00166	CcSEcCtD
Mitotane—Headache—Cladribine—multiple sclerosis	0.000273	0.00166	CcSEcCtD
Mitotane—Vision blurred—Prednisolone—multiple sclerosis	0.000271	0.00165	CcSEcCtD
Mitotane—Hypotension—Mitoxantrone—multiple sclerosis	0.000267	0.00163	CcSEcCtD
Mitotane—Visual impairment—Betamethasone—multiple sclerosis	0.000266	0.00162	CcSEcCtD
Mitotane—Visual impairment—Dexamethasone—multiple sclerosis	0.000266	0.00162	CcSEcCtD
Mitotane—Mental disorder—Methylprednisolone—multiple sclerosis	0.000266	0.00162	CcSEcCtD
Mitotane—Malnutrition—Methylprednisolone—multiple sclerosis	0.000264	0.00161	CcSEcCtD
Mitotane—Breast disorder—Methotrexate—multiple sclerosis	0.000262	0.0016	CcSEcCtD
Mitotane—Hypersensitivity—Azathioprine—multiple sclerosis	0.000261	0.00159	CcSEcCtD
Mitotane—Dysgeusia—Triamcinolone—multiple sclerosis	0.000259	0.00158	CcSEcCtD
Mitotane—Nausea—Cladribine—multiple sclerosis	0.000258	0.00157	CcSEcCtD
Mitotane—Vertigo—Prednisolone—multiple sclerosis	0.000258	0.00157	CcSEcCtD
Mitotane—Eye disorder—Betamethasone—multiple sclerosis	0.000258	0.00157	CcSEcCtD
Mitotane—Eye disorder—Dexamethasone—multiple sclerosis	0.000258	0.00157	CcSEcCtD
Mitotane—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000257	0.00156	CcSEcCtD
Mitotane—Somnolence—Mitoxantrone—multiple sclerosis	0.000254	0.00155	CcSEcCtD
Mitotane—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000252	0.00153	CcSEcCtD
Mitotane—Angiopathy—Betamethasone—multiple sclerosis	0.00025	0.00152	CcSEcCtD
Mitotane—Angiopathy—Dexamethasone—multiple sclerosis	0.00025	0.00152	CcSEcCtD
Mitotane—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000249	0.00151	CcSEcCtD
Mitotane—Hypertension—Prednisolone—multiple sclerosis	0.000248	0.00151	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000248	0.00219	CbGpPWpGaD
Mitotane—Pain—Mitoxantrone—multiple sclerosis	0.000245	0.00149	CcSEcCtD
Mitotane—Diarrhoea—Azathioprine—multiple sclerosis	0.000242	0.00147	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—IL2—multiple sclerosis	0.000241	0.00213	CbGpPWpGaD
Mitotane—Vertigo—Triamcinolone—multiple sclerosis	0.000238	0.00145	CcSEcCtD
Mitotane—Vertigo—Methylprednisolone—multiple sclerosis	0.000237	0.00144	CcSEcCtD
Mitotane—Connective tissue disorder—Prednisone—multiple sclerosis	0.000236	0.00144	CcSEcCtD
Mitotane—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000236	0.00144	CcSEcCtD
Mitotane—Neutropenia—Methotrexate—multiple sclerosis	0.000234	0.00143	CcSEcCtD
Mitotane—Dizziness—Azathioprine—multiple sclerosis	0.000234	0.00143	CcSEcCtD
Mitotane—Shock—Prednisolone—multiple sclerosis	0.000231	0.00141	CcSEcCtD
Mitotane—Hypertension—Triamcinolone—multiple sclerosis	0.000228	0.00139	CcSEcCtD
Mitotane—Hypertension—Methylprednisolone—multiple sclerosis	0.000228	0.00139	CcSEcCtD
Mitotane—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000226	0.00138	CcSEcCtD
Mitotane—Vomiting—Azathioprine—multiple sclerosis	0.000225	0.00137	CcSEcCtD
Mitotane—Eye disorder—Prednisone—multiple sclerosis	0.000224	0.00137	CcSEcCtD
Mitotane—Infestation NOS—Methotrexate—multiple sclerosis	0.000223	0.00136	CcSEcCtD
Mitotane—Infestation—Methotrexate—multiple sclerosis	0.000223	0.00136	CcSEcCtD
Mitotane—Drowsiness—Methotrexate—multiple sclerosis	0.000223	0.00136	CcSEcCtD
Mitotane—Rash—Azathioprine—multiple sclerosis	0.000223	0.00136	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000223	0.00136	CcSEcCtD
Mitotane—Dermatitis—Azathioprine—multiple sclerosis	0.000223	0.00136	CcSEcCtD
Mitotane—Flushing—Prednisone—multiple sclerosis	0.000223	0.00136	CcSEcCtD
Mitotane—Headache—Azathioprine—multiple sclerosis	0.000222	0.00135	CcSEcCtD
Mitotane—Angiopathy—Prednisone—multiple sclerosis	0.000218	0.00133	CcSEcCtD
Mitotane—Confusional state—Methylprednisolone—multiple sclerosis	0.000217	0.00132	CcSEcCtD
Mitotane—Vertigo—Dexamethasone—multiple sclerosis	0.000216	0.00131	CcSEcCtD
Mitotane—Vertigo—Betamethasone—multiple sclerosis	0.000216	0.00131	CcSEcCtD
Mitotane—Infection—Triamcinolone—multiple sclerosis	0.000214	0.00131	CcSEcCtD
Mitotane—Infection—Methylprednisolone—multiple sclerosis	0.000214	0.0013	CcSEcCtD
Mitotane—CYP11B1—Metabolism—SRM—multiple sclerosis	0.000213	0.00188	CbGpPWpGaD
Mitotane—Haematuria—Methotrexate—multiple sclerosis	0.000213	0.0013	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000213	0.00188	CbGpPWpGaD
Mitotane—Shock—Triamcinolone—multiple sclerosis	0.000212	0.00129	CcSEcCtD
Mitotane—Shock—Methylprednisolone—multiple sclerosis	0.000212	0.00129	CcSEcCtD
Mitotane—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000211	0.00129	CcSEcCtD
Mitotane—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000211	0.00129	CcSEcCtD
Mitotane—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000211	0.00128	CcSEcCtD
Mitotane—Paraesthesia—Prednisolone—multiple sclerosis	0.000211	0.00128	CcSEcCtD
Mitotane—Mental disorder—Prednisone—multiple sclerosis	0.00021	0.00128	CcSEcCtD
Mitotane—Nausea—Azathioprine—multiple sclerosis	0.00021	0.00128	CcSEcCtD
Mitotane—Skin disorder—Methylprednisolone—multiple sclerosis	0.000209	0.00127	CcSEcCtD
Mitotane—Malnutrition—Prednisone—multiple sclerosis	0.000209	0.00127	CcSEcCtD
Mitotane—Hypertension—Betamethasone—multiple sclerosis	0.000207	0.00126	CcSEcCtD
Mitotane—Hypertension—Dexamethasone—multiple sclerosis	0.000207	0.00126	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—IL2—multiple sclerosis	0.000206	0.00182	CbGpPWpGaD
Mitotane—Asthenia—Mitoxantrone—multiple sclerosis	0.000205	0.00125	CcSEcCtD
Mitotane—Hypotension—Methylprednisolone—multiple sclerosis	0.000201	0.00123	CcSEcCtD
Mitotane—Pain—Prednisolone—multiple sclerosis	0.000201	0.00122	CcSEcCtD
Mitotane—Hepatitis—Methotrexate—multiple sclerosis	0.000201	0.00122	CcSEcCtD
Mitotane—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000198	0.00121	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—POMC—multiple sclerosis	0.000198	0.00174	CbGpPWpGaD
Mitotane—Vision blurred—Prednisone—multiple sclerosis	0.000197	0.0012	CcSEcCtD
Mitotane—Urethral disorder—Methotrexate—multiple sclerosis	0.000197	0.0012	CcSEcCtD
Mitotane—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000196	0.00119	CcSEcCtD
Mitotane—Infection—Dexamethasone—multiple sclerosis	0.000195	0.00118	CcSEcCtD
Mitotane—Infection—Betamethasone—multiple sclerosis	0.000195	0.00118	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000194	0.00171	CbGpPWpGaD
Mitotane—Paraesthesia—Triamcinolone—multiple sclerosis	0.000194	0.00118	CcSEcCtD
Mitotane—Feeling abnormal—Prednisolone—multiple sclerosis	0.000193	0.00118	CcSEcCtD
Mitotane—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000193	0.00118	CcSEcCtD
Mitotane—Visual impairment—Methotrexate—multiple sclerosis	0.000193	0.00118	CcSEcCtD
Mitotane—Anaemia—Prednisone—multiple sclerosis	0.000193	0.00118	CcSEcCtD
Mitotane—Shock—Dexamethasone—multiple sclerosis	0.000193	0.00117	CcSEcCtD
Mitotane—Shock—Betamethasone—multiple sclerosis	0.000193	0.00117	CcSEcCtD
Mitotane—Nervous system disorder—Betamethasone—multiple sclerosis	0.000192	0.00117	CcSEcCtD
Mitotane—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000192	0.00117	CcSEcCtD
Mitotane—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000192	0.00117	CcSEcCtD
Mitotane—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000192	0.00117	CcSEcCtD
Mitotane—Dyspepsia—Triamcinolone—multiple sclerosis	0.00019	0.00116	CcSEcCtD
Mitotane—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00019	0.00115	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—TGFB1—multiple sclerosis	0.000188	0.00166	CbGpPWpGaD
Mitotane—Vertigo—Prednisone—multiple sclerosis	0.000188	0.00114	CcSEcCtD
Mitotane—Eye disorder—Methotrexate—multiple sclerosis	0.000187	0.00114	CcSEcCtD
Mitotane—Anorexia—Dexamethasone—multiple sclerosis	0.000187	0.00114	CcSEcCtD
Mitotane—Anorexia—Betamethasone—multiple sclerosis	0.000187	0.00114	CcSEcCtD
Mitotane—Pain—Triamcinolone—multiple sclerosis	0.000185	0.00112	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—MAPK1—multiple sclerosis	0.000184	0.00163	CbGpPWpGaD
Mitotane—FDX1—Metabolism—BCHE—multiple sclerosis	0.000183	0.00162	CbGpPWpGaD
Mitotane—Hypotension—Betamethasone—multiple sclerosis	0.000183	0.00111	CcSEcCtD
Mitotane—Hypotension—Dexamethasone—multiple sclerosis	0.000183	0.00111	CcSEcCtD
Mitotane—CYP11A1—Metabolism—SRM—multiple sclerosis	0.000182	0.00161	CbGpPWpGaD
Mitotane—Angiopathy—Methotrexate—multiple sclerosis	0.000182	0.00111	CcSEcCtD
Mitotane—Vomiting—Mitoxantrone—multiple sclerosis	0.000182	0.00111	CcSEcCtD
Mitotane—Hypertension—Prednisone—multiple sclerosis	0.00018	0.0011	CcSEcCtD
Mitotane—Rash—Mitoxantrone—multiple sclerosis	0.00018	0.0011	CcSEcCtD
Mitotane—Dermatitis—Mitoxantrone—multiple sclerosis	0.00018	0.0011	CcSEcCtD
Mitotane—Headache—Mitoxantrone—multiple sclerosis	0.000179	0.00109	CcSEcCtD
Mitotane—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000178	0.00108	CcSEcCtD
Mitotane—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000177	0.00108	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000177	0.00108	CcSEcCtD
Mitotane—Paraesthesia—Dexamethasone—multiple sclerosis	0.000176	0.00107	CcSEcCtD
Mitotane—Paraesthesia—Betamethasone—multiple sclerosis	0.000176	0.00107	CcSEcCtD
Mitotane—Mental disorder—Methotrexate—multiple sclerosis	0.000176	0.00107	CcSEcCtD
Mitotane—Malnutrition—Methotrexate—multiple sclerosis	0.000175	0.00106	CcSEcCtD
Mitotane—Hypersensitivity—Prednisolone—multiple sclerosis	0.000173	0.00105	CcSEcCtD
Mitotane—Dyspepsia—Dexamethasone—multiple sclerosis	0.000172	0.00105	CcSEcCtD
Mitotane—Dyspepsia—Betamethasone—multiple sclerosis	0.000172	0.00105	CcSEcCtD
Mitotane—Dysgeusia—Methotrexate—multiple sclerosis	0.000171	0.00104	CcSEcCtD
Mitotane—Body temperature increased—Triamcinolone—multiple sclerosis	0.000171	0.00104	CcSEcCtD
Mitotane—Decreased appetite—Betamethasone—multiple sclerosis	0.00017	0.00104	CcSEcCtD
Mitotane—Decreased appetite—Dexamethasone—multiple sclerosis	0.00017	0.00104	CcSEcCtD
Mitotane—Nausea—Mitoxantrone—multiple sclerosis	0.00017	0.00103	CcSEcCtD
Mitotane—Infection—Prednisone—multiple sclerosis	0.000169	0.00103	CcSEcCtD
Mitotane—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000169	0.00103	CcSEcCtD
Mitotane—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000169	0.00103	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—POMC—multiple sclerosis	0.000169	0.00149	CbGpPWpGaD
Mitotane—Shock—Prednisone—multiple sclerosis	0.000168	0.00102	CcSEcCtD
Mitotane—Pain—Dexamethasone—multiple sclerosis	0.000167	0.00102	CcSEcCtD
Mitotane—Pain—Betamethasone—multiple sclerosis	0.000167	0.00102	CcSEcCtD
Mitotane—Nervous system disorder—Prednisone—multiple sclerosis	0.000167	0.00102	CcSEcCtD
Mitotane—Skin disorder—Prednisone—multiple sclerosis	0.000166	0.00101	CcSEcCtD
Mitotane—Vision blurred—Methotrexate—multiple sclerosis	0.000165	0.001	CcSEcCtD
Mitotane—Anorexia—Prednisone—multiple sclerosis	0.000163	0.00099	CcSEcCtD
Mitotane—Anaemia—Methotrexate—multiple sclerosis	0.000161	0.000983	CcSEcCtD
Mitotane—Feeling abnormal—Betamethasone—multiple sclerosis	0.000161	0.000983	CcSEcCtD
Mitotane—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000161	0.000983	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—TGFB1—multiple sclerosis	0.000161	0.00142	CbGpPWpGaD
Mitotane—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000159	0.000968	CcSEcCtD
Mitotane—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000159	0.000966	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—MAPK1—multiple sclerosis	0.000158	0.00139	CbGpPWpGaD
Mitotane—Vertigo—Methotrexate—multiple sclerosis	0.000157	0.000956	CcSEcCtD
Mitotane—Dizziness—Prednisolone—multiple sclerosis	0.000155	0.000945	CcSEcCtD
Mitotane—Asthenia—Triamcinolone—multiple sclerosis	0.000155	0.000943	CcSEcCtD
Mitotane—Body temperature increased—Betamethasone—multiple sclerosis	0.000155	0.000943	CcSEcCtD
Mitotane—Body temperature increased—Dexamethasone—multiple sclerosis	0.000155	0.000943	CcSEcCtD
Mitotane—Asthenia—Methylprednisolone—multiple sclerosis	0.000154	0.000941	CcSEcCtD
Mitotane—Paraesthesia—Prednisone—multiple sclerosis	0.000153	0.000933	CcSEcCtD
Mitotane—CYP11B1—Metabolism—CYP27B1—multiple sclerosis	0.00015	0.00133	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP24A1—multiple sclerosis	0.00015	0.00133	CbGpPWpGaD
Mitotane—Dyspepsia—Prednisone—multiple sclerosis	0.00015	0.000914	CcSEcCtD
Mitotane—Decreased appetite—Prednisone—multiple sclerosis	0.000148	0.000903	CcSEcCtD
Mitotane—Rash—Prednisolone—multiple sclerosis	0.000148	0.000901	CcSEcCtD
Mitotane—Dermatitis—Prednisolone—multiple sclerosis	0.000148	0.0009	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000148	0.000899	CcSEcCtD
Mitotane—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000147	0.000897	CcSEcCtD
Mitotane—Headache—Prednisolone—multiple sclerosis	0.000147	0.000895	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000147	0.0013	CbGpPWpGaD
Mitotane—Confusional state—Methotrexate—multiple sclerosis	0.000144	0.000875	CcSEcCtD
Mitotane—Dizziness—Triamcinolone—multiple sclerosis	0.000143	0.000869	CcSEcCtD
Mitotane—Dizziness—Methylprednisolone—multiple sclerosis	0.000142	0.000867	CcSEcCtD
Mitotane—Infection—Methotrexate—multiple sclerosis	0.000142	0.000862	CcSEcCtD
Mitotane—Feeling abnormal—Prednisone—multiple sclerosis	0.000141	0.000856	CcSEcCtD
Mitotane—Asthenia—Dexamethasone—multiple sclerosis	0.00014	0.000856	CcSEcCtD
Mitotane—Asthenia—Betamethasone—multiple sclerosis	0.00014	0.000856	CcSEcCtD
Mitotane—Nervous system disorder—Methotrexate—multiple sclerosis	0.00014	0.000851	CcSEcCtD
Mitotane—Thrombocytopenia—Methotrexate—multiple sclerosis	0.00014	0.00085	CcSEcCtD
Mitotane—Nausea—Prednisolone—multiple sclerosis	0.000139	0.000849	CcSEcCtD
Mitotane—Skin disorder—Methotrexate—multiple sclerosis	0.000138	0.000843	CcSEcCtD
Mitotane—CYP11B1—Metabolism—GPC5—multiple sclerosis	0.000137	0.00121	CbGpPWpGaD
Mitotane—Vomiting—Triamcinolone—multiple sclerosis	0.000137	0.000836	CcSEcCtD
Mitotane—Vomiting—Methylprednisolone—multiple sclerosis	0.000137	0.000834	CcSEcCtD
Mitotane—Rash—Triamcinolone—multiple sclerosis	0.000136	0.000829	CcSEcCtD
Mitotane—Dermatitis—Triamcinolone—multiple sclerosis	0.000136	0.000828	CcSEcCtD
Mitotane—Anorexia—Methotrexate—multiple sclerosis	0.000136	0.000827	CcSEcCtD
Mitotane—Rash—Methylprednisolone—multiple sclerosis	0.000136	0.000827	CcSEcCtD
Mitotane—Dermatitis—Methylprednisolone—multiple sclerosis	0.000136	0.000826	CcSEcCtD
Mitotane—Headache—Triamcinolone—multiple sclerosis	0.000135	0.000823	CcSEcCtD
Mitotane—Headache—Methylprednisolone—multiple sclerosis	0.000135	0.000822	CcSEcCtD
Mitotane—Body temperature increased—Prednisone—multiple sclerosis	0.000135	0.000821	CcSEcCtD
Mitotane—Diarrhoea—Betamethasone—multiple sclerosis	0.000134	0.000816	CcSEcCtD
Mitotane—Diarrhoea—Dexamethasone—multiple sclerosis	0.000134	0.000816	CcSEcCtD
Mitotane—Hypotension—Methotrexate—multiple sclerosis	0.000133	0.000811	CcSEcCtD
Mitotane—Dizziness—Betamethasone—multiple sclerosis	0.000129	0.000789	CcSEcCtD
Mitotane—Dizziness—Dexamethasone—multiple sclerosis	0.000129	0.000789	CcSEcCtD
Mitotane—CYP11A1—Metabolism—CYP27B1—multiple sclerosis	0.000128	0.00113	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP24A1—multiple sclerosis	0.000128	0.00113	CbGpPWpGaD
Mitotane—Nausea—Triamcinolone—multiple sclerosis	0.000128	0.000781	CcSEcCtD
Mitotane—Paraesthesia—Methotrexate—multiple sclerosis	0.000128	0.000779	CcSEcCtD
Mitotane—Nausea—Methylprednisolone—multiple sclerosis	0.000128	0.000779	CcSEcCtD
Mitotane—Somnolence—Methotrexate—multiple sclerosis	0.000127	0.000772	CcSEcCtD
Mitotane—Hypersensitivity—Prednisone—multiple sclerosis	0.000126	0.000765	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000126	0.00111	CbGpPWpGaD
Mitotane—Dyspepsia—Methotrexate—multiple sclerosis	0.000125	0.000764	CcSEcCtD
Mitotane—Vomiting—Dexamethasone—multiple sclerosis	0.000125	0.000758	CcSEcCtD
Mitotane—Vomiting—Betamethasone—multiple sclerosis	0.000125	0.000758	CcSEcCtD
Mitotane—Decreased appetite—Methotrexate—multiple sclerosis	0.000124	0.000755	CcSEcCtD
Mitotane—Rash—Betamethasone—multiple sclerosis	0.000123	0.000752	CcSEcCtD
Mitotane—Rash—Dexamethasone—multiple sclerosis	0.000123	0.000752	CcSEcCtD
Mitotane—Dermatitis—Dexamethasone—multiple sclerosis	0.000123	0.000751	CcSEcCtD
Mitotane—Dermatitis—Betamethasone—multiple sclerosis	0.000123	0.000751	CcSEcCtD
Mitotane—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000123	0.000749	CcSEcCtD
Mitotane—Headache—Dexamethasone—multiple sclerosis	0.000123	0.000747	CcSEcCtD
Mitotane—Headache—Betamethasone—multiple sclerosis	0.000123	0.000747	CcSEcCtD
Mitotane—Asthenia—Prednisone—multiple sclerosis	0.000122	0.000745	CcSEcCtD
Mitotane—Pain—Methotrexate—multiple sclerosis	0.000122	0.000742	CcSEcCtD
Mitotane—CYP11A1—Metabolism—GPC5—multiple sclerosis	0.000117	0.00104	CbGpPWpGaD
Mitotane—Feeling abnormal—Methotrexate—multiple sclerosis	0.000117	0.000715	CcSEcCtD
Mitotane—Diarrhoea—Prednisone—multiple sclerosis	0.000117	0.000711	CcSEcCtD
Mitotane—Nausea—Dexamethasone—multiple sclerosis	0.000116	0.000708	CcSEcCtD
Mitotane—Nausea—Betamethasone—multiple sclerosis	0.000116	0.000708	CcSEcCtD
Mitotane—CYP11B1—Metabolism—RRM1—multiple sclerosis	0.000114	0.00101	CbGpPWpGaD
Mitotane—Dizziness—Prednisone—multiple sclerosis	0.000113	0.000687	CcSEcCtD
Mitotane—Body temperature increased—Methotrexate—multiple sclerosis	0.000113	0.000686	CcSEcCtD
Mitotane—FDX1—Metabolism—APOE—multiple sclerosis	0.00011	0.000975	CbGpPWpGaD
Mitotane—Vomiting—Prednisone—multiple sclerosis	0.000108	0.00066	CcSEcCtD
Mitotane—Rash—Prednisone—multiple sclerosis	0.000108	0.000655	CcSEcCtD
Mitotane—Dermatitis—Prednisone—multiple sclerosis	0.000107	0.000654	CcSEcCtD
Mitotane—Headache—Prednisone—multiple sclerosis	0.000107	0.000651	CcSEcCtD
Mitotane—Hypersensitivity—Methotrexate—multiple sclerosis	0.000105	0.00064	CcSEcCtD
Mitotane—Asthenia—Methotrexate—multiple sclerosis	0.000102	0.000623	CcSEcCtD
Mitotane—Nausea—Prednisone—multiple sclerosis	0.000101	0.000617	CcSEcCtD
Mitotane—Diarrhoea—Methotrexate—multiple sclerosis	9.75e-05	0.000594	CcSEcCtD
Mitotane—CYP11A1—Metabolism—RRM1—multiple sclerosis	9.74e-05	0.00086	CbGpPWpGaD
Mitotane—FDX1—Metabolism—POMC—multiple sclerosis	9.48e-05	0.000838	CbGpPWpGaD
Mitotane—Dizziness—Methotrexate—multiple sclerosis	9.42e-05	0.000574	CcSEcCtD
Mitotane—Vomiting—Methotrexate—multiple sclerosis	9.06e-05	0.000552	CcSEcCtD
Mitotane—Rash—Methotrexate—multiple sclerosis	8.99e-05	0.000547	CcSEcCtD
Mitotane—Dermatitis—Methotrexate—multiple sclerosis	8.98e-05	0.000547	CcSEcCtD
Mitotane—Headache—Methotrexate—multiple sclerosis	8.93e-05	0.000544	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.83e-05	0.00078	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ALB—multiple sclerosis	8.64e-05	0.000764	CbGpPWpGaD
Mitotane—Nausea—Methotrexate—multiple sclerosis	8.47e-05	0.000516	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.58e-05	0.00067	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.55e-05	0.000667	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.92e-05	0.000611	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—BCHE—multiple sclerosis	6.54e-05	0.000577	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.49e-05	0.000573	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.92e-05	0.000523	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—BCHE—multiple sclerosis	5.59e-05	0.000494	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—APOE—multiple sclerosis	3.93e-05	0.000347	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—POMC—multiple sclerosis	3.38e-05	0.000298	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—APOE—multiple sclerosis	3.36e-05	0.000297	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ALB—multiple sclerosis	3.08e-05	0.000272	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—POMC—multiple sclerosis	2.89e-05	0.000255	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ALB—multiple sclerosis	2.63e-05	0.000233	CbGpPWpGaD
